Mediengine
About:
Mediengine develops drugs and materials for the treatment of metabolic diseases based on energy regulation.
Website: https://mediandgene.com
Top Investors: TIPS Program, Korea Investment Accelerator
Description:
Total Funding Amount:
1B KRW
Headquarters Location:
Seoul, Seoul-t'ukpyolsi, South Korea
Founded Date:
2021-01-01
Founders:
Number of Employees:
Last Funding Date:
2022-12-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai